Your session is about to expire
← Back to Search
Personal Health Library App for Formerly Incarcerated Individuals
Study Summary
This trial is testing a new app called PerHL to see if it helps formerly incarcerated people manage their health.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have issues with thinking or memory.I am 18 years old or older.You have at least one long-term health problem.I have a visual impairment.You are unable to communicate effectively in the language needed for the study.
- Group 1: Control - MyChart
- Group 2: Access to Personal Health Library (PerHL) + MyChart
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What are the aims of this experiment?
"The primary aim of this study, spanning 3 months post-enrolment, is to evaluate participants' usage of personal health information technology. Secondary objectives are to assess general self-efficacy through a participant survey (in development), gauge the perceived usefulness of an app via survey responses (also in development) and measure attitude towards using technology with a third survey instrument."
Are recruitment efforts underway for this experimental research?
"This research endeavour, which was initially posted on January 1st 2023 and last updated in July 8th 2022 according to clinicaltrials.gov, is not currently open for recruitment. However, there are alternate medical trials that require participants at this time."
Share this study with friends
Copy Link
Messenger